glp-1 weight loss new orleans Drugs: 6 Things We've Learned About Their Effects glp-1 treatment new orleans GLP-1

2024 Jul 13;15(1):5912

They show how much muscle versus fat is lost and where fat is lost from

In this latest article, Hannah Witt explores the science behind GLP-1 receptor agonists and provides practical guidance for strength and conditioning professionals working with clients using these medications

Abbreviations GLP-1: Glucagon-like peptide-1 GLP-1RA: Glucagon-like peptide-1 receptor agonist T2DM: Type-2 diabetes mellitus DPP-4: Dipeptidyl peptidase 4 HbA1c: Hemoglobin A1c NASH: Non-alcoholic steatohepatitis NAFLD: Non-alcoholic fatty liver disease Camp: Cyclic adenosine monophosphate PKA: Protein kinase A EPAC: Exchange protein directly activated by cAMP PI3K: Phosphoinositide 3-kinase PYY: Peptide YY CCK: Cholecystokinin GLUT4: Glucose transporter type 4 mTORC1: Mammalian target of rapamycin complex 1 References Ahrn B (2015) Hepato-incretin function of GLP-1: novel concept and target in type 1 diabetes

The PlexusDx Precision Peptide Genetic Test identifies your variants in GLP1R, GIPR, FTO, and MC4R genes, revealing how efficiently your receptors bind GLP-1 molecules and how your metabolism responds to peptide hormones